Medica 2011 opens with FDA for the portable line

16 November 2011 - Trade fairs & Congresses -

ASAlaser inaugurates its participation at Medica 2011 with an auspicious start: the portable line is now cleared by the prestigious U.S. FDA.

"The clearance by U.S. Food and Drug Administration – says Roberto Marchesini,  ASAlaser Managing Director - is an important added value for our equipment: their effectiveness is further confirmed by this international recognition. This is a great piece of news that arrives during  Dusseldorf Trade Fair, where we can take the chance to meet our European and international partners and to establish new business relationships".

Besides being a stage for the presentation of the redesigned corporate brand (ASAlaser - Research and Therapeutic Solutions) and of the new operating system with easy-to-use Touch 1.0 software, the International Fair of Medicine and Hospital Technology represents a new milestone for ASAlaser. "We have been  working for almost 30 years to open new roads, pushing the limits and reaching new horizons - confirms Zaghetto Lucio, CEO of ASAlaser - this new clearance will enable us to achieve other goals".

 

You might also be interested in ...

See all articles

ASAlaser @ Pecs - Hungary
News - 13/11/2024
Thanks to the collaboration with the local distributor Procardia & Meddevice, present with its own stand, the company staff were able to meet long-standing customers and, at the same time, to...
MLS Laser Therapy Speech in Brasov, Romania
News - 30/10/2024
MLS® Laser Therapy and some of its flagship devices could not miss out on attending the “National Congress of Physical Medicine and Rehabilitation” in Brasov (Romania, 16-19 October).
ASA laser therapies speech at Rehabilitaja
News - 29/10/2024
A corner dedicated to the HIRO, M-Hi and M6 devices in the exhibition space of the Polish distributor Meden Inmed and two speeches.
MLS Laser Therapy for TMD
Blog - 22/10/2025
A recent publication from Chulalongkorn University (Thailand) demonstrated how an integrated and conservative approach, supported by MLS® Laser Therapy, can offer highly effective clinical results.
M-Hi laser training UK
News - 22/10/2025
From 30 September to 3 October, the tour visited three cities in the United Kingdom, involving physiotherapists and specialists who have chosen the M-Hi and HIRO TT laser systems.
Press - 07/10/2025
Recent research and pilot studies highlight the benefits of laser therapy in treating radiodermatitis and peripheral neuropathy induced by radiation and chemotherapy for breast cancer.